Sutro Biopharma STRO - Options Chain | InvestorsHub

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Sutro Biopharma Inc (STRO)
Sutro Biopharma Inc (STRO) Options

Sutro Biopharma Inc (STRO)

2.04

0.01

(0.49%)

Closed January 27 4:00PM

Delayed by 15 minutes

2.04

0.00

(0.00%)

After Hours: 6:56PM

Delayed by 15 minutes

STRO Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.15	0.20	0.20	0.175	0.08	66.67 %	153	336	1/24/2025
5.00	0.05	0.10	0.05	0.075	0.00	0.00 %	0	1,655	-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.35	0.75	0.55	0.55	0.00	0.00 %	0	10	-
5.00	2.60	3.90	0.00	3.25	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	$ 90.11 (-38.07%)	8
ACONAclarion Inc	$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	$ 142.62 (-3.12%)	232.88M

Invest-in-America

Invest-in-America 4 weeks ago

STRO: I launched this new iHub board today due to the below-pasted reply I got from GOOGLE's (AI) search routine regarding my following question: "Which (under $5.00) NASDAQ stock is the most likely to SOAR hugely in price on 1-2-25?"

"According to current market analysis, Sutro Biopharma Inc. (STRO), a clinical-stage biopharmaceutical company currently trading under $5, is considered a potential candidate for a significant price jump due to its promising cancer treatment pipeline, particularly its lead drug candidate "luveltamab tazevibulin" currently in mid-phase trials, which could lead to substantial investor interest if clinical trials prove successful; however, investing in any penny stock carries high risk and should be done with thorough research and consideration of potential downsides."

/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
And "TipRanks" gives STRO a "Strong Buy" rating, for what that's worth. (But its Float is 76-Million, which ain't small.)

Sutro Biopharma

Delayed Upgrade Clock